Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517618 | SCV000615340 | benign | not specified | 2016-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314904 | SCV000848637 | likely benign | Inborn genetic diseases | 2016-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000877499 | SCV001020243 | benign | Cornelia de Lange syndrome 3 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962437 | SCV004784490 | likely benign | SMC3-related disorder | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |